Peter Soparkar, See Remarks section at Adverum Biotechnologies, Inc. (ADVM), sold 13,305 shares at $1.07 ($14K) on 2022-09-19, disclosed to the SEC on 2022-09-21.
Open-market sale of $14k ADVM by See Remarks section. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| ADVM | SELL | 2023-03-17 | $10K | — | Filing → |
| ADVM | BUY | 2022-04-20 | $25K | — | Filing → |
| ADVM | BUY | 2021-12-10 | $48K | — | Filing → |